Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
Titel:
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
Auteur:
Perey, L. Paridaens, R. Hawle, H. Zaman, K. Nolé, F. Wildiers, H. Fiche, M. Dietrich, D. Clément, P. Köberle, D. Goldhirsch, A. Thürlimann, B.